TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 37 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,953 | -16.3% | 213,223 | +36.8% | 0.00% | – |
| Q2 2023 | $45,345 | -84.6% | 155,826 | 0.0% | 0.00% | – |
| Q1 2023 | $294,511 | +126844.4% | 155,826 | 0.0% | 0.00% | – |
| Q4 2022 | $232 | -99.9% | 155,826 | -0.2% | 0.00% | – |
| Q3 2022 | $260,000 | -16.7% | 156,158 | 0.0% | 0.00% | – |
| Q2 2022 | $312,000 | -22.4% | 156,158 | +2.0% | 0.00% | – |
| Q1 2022 | $402,000 | +1.0% | 153,060 | +6.4% | 0.00% | – |
| Q4 2021 | $398,000 | -29.4% | 143,912 | -1.3% | 0.00% | – |
| Q3 2021 | $564,000 | -36.9% | 145,745 | +5.7% | 0.00% | – |
| Q2 2021 | $894,000 | +3.6% | 137,822 | +31.3% | 0.00% | – |
| Q1 2021 | $863,000 | +7.5% | 104,954 | +52.8% | 0.00% | – |
| Q4 2020 | $803,000 | – | 68,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
| Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
| Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
| JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
| X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |